WVE - Company ID 0001631574
The table below shows Wave Life Sciences Ltd.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $602.07M | $302.08M | $200.35M | $88.50M | $150.56M | $184.50M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $1.28M | $1.42M | $21.09M | - | $30.00M | $30.00M |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $614.81M |
| $320.39M |
| $235.37M |
| $98.54M |
| $162.56M |
| $230.04M |
| Property, plant & equipment | $7.41M | $10.13M | $13.08M | $17.28M | $22.27M | $29.20M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $638.50M | $352.21M | $274.95M | $146.39M | $207.01M | $279.24M |
| Accounts payable | $15.70M | $16.26M | $12.84M | $16.91M | $7.28M | $13.79M |
| Total current liabilities | $95.06M | $110.95M | $186.44M | $71.52M | $64.20M | $121.04M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $112.27M | $134.82M | $227.44M | $183.60M | $166.63M | $188.59M |
| Retained earnings | -$1.33B | -$1.12B | -$1.02B | -$967.34M | -$805.51M | -$683.27M |
| Total equity | $518.36M | $209.51M | $39.63M | -$45.09M | $32.50M | $82.78M |